Urinalysis: Clinical Trials

9 trials of Urinalysis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 recruiting, 1 not yet recruiting. 9 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 19Completed 6, Recruiting 2, Not yet recruiting 1

Follow Urinalysis: new trials by email Literature Review of Urinalysis trials Research Report on Urinalysis

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau
Neuronavigation-guided single-element focused ultrasound transducer, Lumason, Magnetic Resonance Imaging (MRI) with or without gadolinium contrast agents - Alzheimer Disease, Early Onset
Phase 1Not yet recruitingColumbia University62027-08-012026-05-13
Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers
Psilocybin and D-Serine, Physical Examination, Vital signs - Healthy Volunteers
Phase 1RecruitingHadassah Medical Organization102025-12-112026-02-05
UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients
Physical examination, Electrocardiogram, SF-36 questionnaire - SLE, Lupus
Phase 1RecruitingLiveKidney.Bio102025-01-072025-09-11
Assessment of KM-001 - Safety, Tolerability, and Efficacy in Patients With PPPK1 or PC
KM-001 cream 1% 12 weeks treatment., Physical Examination, Vital Signs - Punctate Palmoplantar Keratoderma Type 1, Pachyonychia Congenita
Phase 1CompletedOrvida Pharma (formerly Kamari Pharma)182023-03-062025-01-15
Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases
Serum chemistry, Hematology, Urinalysis - Punctate Palmoplantar Keratoderma Type 1, Pachyonychia Congenita
Phase 1CompletedOrvida Pharma (formerly Kamari Pharma)142022-07-172025-01-07
KM-001 Cream for Treatment of Pruritus in Adult Patients With Lichen Simplex Chronicus (LSC)
IMP Application KM-001, Chemistry, Hematology - Lichen Simplex Chronicus
Phase 1CompletedOrvida Pharma (formerly Kamari Pharma)552022-05-242024-04-02
Oral Nifedipine to Treat Iron Overload
Nifedipine, Phlebotomy, Urinalysis - Thalassemia, Iron Overload
Phase 1CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)62008-06-202017-07-02
Phase I Study of a Vaccine for Severe Acute Respiratory Syndrome (SARS)
Blood Test, Urine Test, Physical Exam - Healthy
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)102004-12-092017-07-02
Anthrax Vaccine Clinical Trials
Anthrax Vaccine, Blood Chemistry, Hematology - Anthrax
Phase 1CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)932004-09-082017-07-02

Conditions studied

Keratosis palmoplantaris papulosa (2)  ·  Pachyonychia Congenita (2)  ·  Alzheimer Disease (1)  ·  Anthrax (1)  ·  Coronavirus Infections (1)  ·  Hemochromatosis (1)  ·  Iron Overload (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Neurodermatitis (1)  ·  Thalassemia (1)  ·  Virus Diseases (1)

Sponsors

Orvida Pharma (formerly Kamari Pharma) (3)  ·  Columbia University (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Hadassah Medical Organization (1)  ·  LiveKidney.Bio (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)

Countries

United States (5)  ·  Israel (2)  ·  Germany (1)  ·  United Kingdom (1)

Top investigators

Clay W. Mash, Ph.D. (1)  ·  Grace McIlvain, PhD (1)

Results publications

PMID 37975597